Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aevi Genomic Medicine Inc (NASDAQ:GNMX)

1.38
Delayed Data
As of 4:00pm ET
 -0.06 / -4.17%
Today’s Change
0.98
Today|||52-Week Range
6.89
-73.36%
Year-to-Date
No recent news for Aevi Genomic Medicine Inc.

Today’s Trading

Previous close1.44
Today’s open1.44
Day’s range1.36 - 1.49
Volume289,395
Average volume (3 months)753,483
Market cap$53.4M
Dividend yield--
Data as of 4:00pm ET, 06/27/2017

Growth & Valuation

Earnings growth (last year)+17.93%
Earnings growth (this year)+8.82%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.53

Competitors

 Today’s
change
Today’s
% change
RGLSRegulus Therapeutics...+0.03+2.94%
PLXPPLX Pharma Inc-0.15-2.38%
JNPJuniper Pharmaceutic...-0.25-4.95%
ITEKInotek Pharmaceutica...+0.05+2.63%
Data as of 4:00pm ET, 06/27/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$0.00
Annual profit (last year)-$41.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael F. Cola
Chief Financial &
Principal Accounting Officer
Brian D. Piper
Corporate headquarters
Wayne, Pennsylvania

Forecasts